Volume 29, Number 3—March 2023
CME ACTIVITY - Research
Clonal Expansion of Multidrug-Resistant Streptococcus dysgalactiae Subspecies equisimilis Causing Bacteremia, Japan, 2005–2021
Table 1
Characteristics of 133 patients with Streptococcus dysgalactiae subspecies equisimilis bacteremia, Japan, 2005–2021*
Characteristic | Value |
---|---|
Median age, y (IQR) |
81.0 (72.0–88.0) |
Age group, y | |
<30 | 1 (0.8) |
30–39 | 4 (3.0) |
40–49 | 5 (3.6) |
50–59 | 6 (4.5) |
60–69 | 12 (9.0) |
70–79 | 29 (21.8) |
80–89 | 50 (37.6) |
>90 |
26 (19.5) |
Sex | |
M | 72 (54.1) |
F |
61 (45.9) |
Medical history | |
No underlying conditions | 15 (11.3) |
Solid organ tumor† | 36 (27.1) |
History of surgery, n = 36 | 15 (41.7) |
Active malignancy, n = 36‡ | 22 (61.1) |
Metastasis, n = 36 | 10 (27.8) |
Hematologic malignancy | 6 (4.5) |
Hematopoietic stem cell transplant, n = 6 | |
Cardiovascular disease | 21 (15.8) |
Cerebral artery diseases | 38 (28.6) |
Chronic kidney diseases | 27 (20.3) |
Diabetes mellitus | 22 (16.5) |
Dementia | 31 (23.3) |
Collagen diseases | 8 (6.0) |
Chronic lung diseases | 7 (5.3) |
HIV | 0 |
Chemotherapy | 12 (9.0) |
Immune suppressive therapy | 6 (4.5) |
Neutropenia, neutrophil count <500 cells/µL | 5 (3.8) |
*Values are no. (%) except as indicated. For patients with multiple episodes, variables for the first episode are described. †Ten patients with prostate cancer; 8 with cervical cancer; 7 with colon, rectal, or anal cancer; 3 with lung cancer; 2 with stomach cancer; 2 with endometrial cancer; 2 with bladder cancer; 2 with breast cancer; and 1 with cancer categorized as other (esophageal cancer, ovarian cancer, pharyngeal cancer, salivary gland cancer, vaginal cancer, and extramammary Paget’s disease), including duplicates. ‡Treated within 5 years.